Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,098 | -13,405 | -4,577 | -26,725 | -23,382 |
| Depreciation Amortization | 12 | 8 | 4 | 11 | 8 |
| Accounts payable and accrued liabilities | 1,284 | 959 | -436 | -946 | -1,354 |
| Other Working Capital | 4,557 | 1,798 | -775 | -3,476 | -1,652 |
| Other Operating Activity | -198 | -223 | 755 | 16,580 | 16,731 |
| Operating Cash Flow | $-17,442 | $-10,864 | $-5,028 | $-14,556 | $-9,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34 | -34 | -34 | -7 | -7 |
| Other Investing Activity | 0 | 0 | 0 | -14,750 | -14,750 |
| Investing Cash Flow | $-34 | $-34 | $-34 | $-14,757 | $-14,757 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 109,294 | 94,759 |
| Other Financing Activity | -15 | -15 | -15 | 0 | 0 |
| Financing Cash Flow | $-15 | $-15 | $-15 | $109,294 | $94,759 |
| Beginning Cash Position | 94,430 | 94,430 | 94,430 | 14,450 | 14,450 |
| End Cash Position | 76,938 | 83,517 | 89,352 | 94,430 | 84,802 |
| Net Cash Flow | $-17,492 | $-10,913 | $-5,078 | $79,980 | $70,352 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,442 | -10,864 | -5,028 | -14,556 | -9,650 |
| Capital Expenditure | -34 | -34 | -34 | -7 | -7 |
| Free Cash Flow | -17,476 | -10,898 | -5,062 | -14,564 | -9,657 |